microRNA-224, retinoic acid receptor gamma, epigenetic silencing of miR-490-3p, and inhibition of long non-coding RNA-CTD903 promotes aggressive CRC phenotype by activation of the Wnt/β-catenin signaling pathway [27–30]. The gene discussed is RARG; the disease is colorectal carcinoma.